J Infect Dis. 1992 Mar;165(3):545-8.

Studies of antibody-dependent enhancement of human immunodeficiency virus (HIV) type 1 infection mediated by Fc receptors using sera from recipients of a recombinant gp160 experimental HIV-1 vaccine.

Haubrich RH, Takeda A, Koff W, Smith G, Ennis FA.

Source

University of Massachusetts Medical Center, Worcester.

Abstract

Subneutralizing concentrations of sera from human immunodeficiency virus (HIV)-1-infected patients augment HIV infection mediated by Fc receptor uptake by human monocytes and the monocytic cell line U937. Antibody-dependent enhancement (ADE) and neutralization activity were studied in the sera of HIV-1 antibody-negative volunteers who had been immunized with three 40-micrograms doses of a recombinant gp160 (rgp160) candidate HIV vaccine. Volunteers were vaccinated with rgp160 or a hepatitis B vaccine as a control on days 0, 30, and 180. Sera were obtained before and after three doses of vaccine and were tested for ADE and neutralization activity. Serum samples collected before vaccination showed neither neutralization nor ADE activity. Thirteen sera from volunteers who received gp160 and four from placebo recipients failed to show ADE. Three sera showed low levels of neutralization of strain IIIB of HIV. Vaccination with this dose of rgp160 produced neutralizing antibodies in some subjects but did not induce detectable enhancing antibodies.

PMID:: 1538159; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

HIV/AIDS - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. NIAID AIDS Vaccine Clinical Trials Network. [J Clin Immunol. 1992]
Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. NIAID AIDS Vaccine Clinical Trials Network.
Montefiori DC, Graham BS, Kliks S, Wright PF. J Clin Immunol. 1992 Nov; 12(6):429-39.
Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytometry and enzyme immunoassays. The AIDS Vaccine Clinical Trials Network. [J Clin Microbiol. 1992]
Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytometry and enzyme immunoassays. The AIDS Vaccine Clinical Trials Network.
Gorse GJ, Frey SE, Newman FK, Belshe RB. J Clin Microbiol. 1992 Oct; 30(10):2606-12.
Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network. [Vaccine. 1994]
Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network.
Gorse GJ, Frey SE, Patel G, Newman FK, Belshe RB. Vaccine. 1994 Aug; 12(10):912-8.
Review How antibodies block HIV infection: paths to an AIDS vaccine. [Trends Biochem Sci. 1992]
Review How antibodies block HIV infection: paths to an AIDS vaccine.
Putney S. Trends Biochem Sci. 1992 May; 17(5):191-6.
Review Human studies in the development of human immunodeficiency virus vaccines. [J Infect Dis. 1995]
Review Human studies in the development of human immunodeficiency virus vaccines.
Dolin R. J Infect Dis. 1995 Nov; 172(5):1175-83.

See reviews... See all...

Cited by 2 PubMed Central articles

Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients. [J Clin Microbiol. 2002]
Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients.
Subbramanian RA, Xu J, Toma E, Morisset R, Cohen EA, Menezes J, Ahmad A. J Clin Microbiol. 2002 Jun; 40(6):2141-6.
Phenotypic and functional changes in peripheral blood monocytes during progression of human immunodeficiency virus infection. Effects of soluble immune complexes, cytokines, subcellular particulates from apoptotic cells, and HIV-1-encoded proteins on monocytes phagocytic function, oxidative burst, transendothelial migration, and cell surface phenotype. [J Clin Invest. 1995]
Phenotypic and functional changes in peripheral blood monocytes during progression of human immunodeficiency virus infection. Effects of soluble immune complexes, cytokines, subcellular particulates from apoptotic cells, and HIV-1-encoded proteins on monocytes phagocytic function, oxidative burst, transendothelial migration, and cell surface phenotype.
Trial J, Birdsall HH, Hallum JA, Crane ML, Rodriguez-Barradas MC, de Jong AL, Krishnan B, Lacke CE, Figdor CG, Rossen RD. J Clin Invest. 1995 Apr; 95(4):1690-701.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Studies of antibody-dependent enhancement of human immunodeficiency virus (HIV) ...
Studies of antibody-dependent enhancement of human immunodeficiency virus (HIV) type 1 infection mediated by Fc receptors using sera from recipients of a recombinant gp160 experimental HIV-1 vaccine.
J Infect Dis. 1992 Mar ;165(3):545-8.

PubMed
Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for t...
Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
Arch Dermatol. 2004 Sep ;140(9):1065-9.

PubMed
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes me...
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.
Ann Intern Med. 2004 Sep 21 ;141(6):421-31.

PubMed
Immunity in hepatitis C infection.
Immunity in hepatitis C infection.
J Infect Dis. 1992 Mar ;165(3):438-43.

PubMed
[Towards the identification of new markers of pancreatic cancer by gene expressi...
[Towards the identification of new markers of pancreatic cancer by gene expression analysis].
Bull Cancer. 2004 Jul-Aug ;91(7-8):593-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Studies of antibody-dependent enhancement of human immunodeficiency virus (HIV) type 1 infection mediated by Fc receptors using sera from recipients of a recombinant gp160 experimental HIV-1 vaccine.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information